Concepedia

Author

Hans Prenen

KU LeuvenORCID

Also Known As

Chow, Wong-Ho, Corley, Douglas A, H PRENEN, H Prenen, H. PRENEN, H. Prenen, H. Prenen ., HANS PRENEN, Hans Prenen, Marc Lambrechts

434

Publications

14.7K

Citations

53

H-Index

129

Concepts

All Affiliations

KU LeuvenAntwerp University HospitalUniversity of AntwerpVIB-KU Leuven Center for Cancer BiologyThe University of Texas MD Anderson Cancer Center
HP

About

Hans Prenen is an author at KU Leuven specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

27

48

3.7K

2

Health Sciences

7

7

333

3

Public Health

4

4

54

4

Engineering

2

2

29

5

Natural Sciences

2

2

58

Hans Prenen

×

101

Publications

9.8K

Citations

41

H-Index

YearCitations

Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

Robert J. Mayer, Eric Van Cutsem, Alfredo Falcone,

New England Journal of Medicine

2015

1.4K

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Eric Van Cutsem, Josep Tabernero, Radek Lakomý,

Journal of Clinical Oncology

2012

1.4K

Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials

Alexander Drilon, Salvatore Siena, Rafał Dziadziuszko,

The Lancet Oncology

2019

516

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

Maria Dêbiec‐Rychter, Jan Cools, Herlinde Dumez,

Gastroenterology

2005

492

MET is required for the recruitment of anti-tumoural neutrophils

Veronica Finisguerra, Giusy Di Conza, Mario Di Matteo,

Nature

2015

487

Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis

Mathias Wenes, Min Shang, Mario Di Matteo,

Cell Metabolism

2016

480

PIK3CA Mutations Are Not a Major Determinant of Resistance to the Epidermal Growth Factor Receptor Inhibitor Cetuximab in Metastatic Colorectal Cancer

Hans Prenen, Jef De Schutter, Bart Jacobs,

Clinical Cancer Research

2009

293

Efficacy of the Kinase Inhibitor SU11248 against Gastrointestinal Stromal Tumor Mutants Refractory to Imatinib Mesylate

Hans Prenen, Jan Cools, Nicole Mentens,

Clinical Cancer Research

2006

275

Podoplanin-Expressing Macrophages Promote Lymphangiogenesis and Lymphoinvasion in Breast Cancer

Paweł Bieniasz-Krzywiec, Rosa Martín‐Pérez, Manuel Ehling,

Cell Metabolism

2019

229

Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients

Ophélia Maertens, Hans Prenen, Maria Dêbiec‐Rychter,

Human Molecular Genetics

2006

211

Page 1